COVID-19 booster vaccination
Showing 1 - 25 of >10,000
Multiple Sclerosis Trial in Derby (Homologous booster, Heterologous booster)
Recruiting
- Multiple Sclerosis
- Homologous booster
- Heterologous booster
-
Derby, ConnecticutGriffin Hospital
Jan 23, 2022
Rheumatoid Arthritis Trial in Seoul (MTX)
Recruiting
- Rheumatoid Arthritis
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 4, 2022
COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19
Not yet recruiting
- COVID-19
- Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
- Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
- (no location specified)
Jun 19, 2023
COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant
Not yet recruiting
- COVID-19
- High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
- +3 more
- (no location specified)
Jun 19, 2023
Vaccine Refusal, COVID-19 Trial (Informational Video, Altruistic Video, Individualistic Video)
Not yet recruiting
- Vaccine Refusal
- COVID-19
- Informational Video
- +2 more
- (no location specified)
Apr 12, 2023
COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)
Not yet recruiting
- COVID-19 Vaccine
- COVID-19
- 50 μg Baiya SARS-CoV-2 Vax 2
- Placebo
-
Bangkok, ThailandQueen Saovabha Memorial Institute
May 23, 2023
COVID Booster in Pregnancy and Lactation
Recruiting
- COVID-19
- Bivalent COVID-19 Booster
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Sep 14, 2022
SARS-CoV-2 Trial (CV0701 Bivalent High dose, CV0701 Bivalent Medium dose, CV0701 Bivalent Low dose)
Not yet recruiting
- SARS-CoV-2
- CV0701 Bivalent High dose
- +4 more
- (no location specified)
Jul 24, 2023
COVID-19 Trial in Wuhan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, ZF2001)
Active, not recruiting
- COVID-19
- Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
- ZF2001
-
Wuhan, Hubei, ChinaHubei Provincial Center for Disease Control and Prevention
Jan 12, 2023
COVID-19 Trial in Philadelphia (COVID Booster text messages)
Enrolling by invitation
- COVID-19
- COVID Booster text messages
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 3, 2023
COVID-19 Trial in Cali (VLA 2001)
Not yet recruiting
- COVID-19
- VLA 2001
-
Cali, Valle, ColombiaCentro de Estudios en Infectología Pediátrica
Sep 15, 2022
COVID-19 Trial (Recombinant variant COVID-19 vaccine (Sf9 cell), Recombinant COVID-19 vaccine (CHO cell), Recombinant COVID-19
Not yet recruiting
- COVID-19
- Recombinant variant COVID-19 vaccine (Sf9 cell)
- +2 more
- (no location specified)
Mar 10, 2023
Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID
Not yet recruiting
- Influenza
- +3 more
- Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
- +2 more
-
Phoenix, Arizona
- +7 more
Aug 30, 2023
COVID-19 Trial in Groningen (AKS-452X)
Recruiting
- COVID-19
- AKS-452X
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 19, 2022
COVID-19 Pandemic Trial (Lyophilized COVID-19 mRNA Vaccine, Sodium chloride)
Not yet recruiting
- COVID-19 Pandemic
- Lyophilized COVID-19 mRNA Vaccine
- Sodium chloride
- (no location specified)
Nov 18, 2022
COVID-19, SARS-CoV-2 Infection Trial in Iloilo City (Recombinant COVID-19 Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),
Recruiting
- COVID-19
- SARS-CoV-2 Infection
- Recombinant COVID-19 Vaccine (Sf9 Cell)
- COVID-19 Vaccine (Vero Cell), Inactivated
-
Iloilo City, PhilippinesIloilo Doctors Hospital
Jul 18, 2022
COVID-19, SARS-CoV-2 Infection Trial in Morelia (Recombinant COVID-19 variant Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- Recombinant COVID-19 variant Vaccine (Sf9 Cell)
- +3 more
-
Morelia, Michoacán De Ocampo, MexicoClínica de Enfermedades Crónicas y de Procedimientos Especiales,
Jul 18, 2022
COVID-19 Vaccines Trial in Marshfield (Reminder/Recall Sent Via Preferred Method of Communication)
Active, not recruiting
- COVID-19 Vaccines
- Reminder/Recall Sent Via Preferred Method of Communication
-
Marshfield, WisconsinMarshfield Clinic Health System
Oct 10, 2022
SARS-CoV-2 Infection Trial (PTX-COVID19-B, Comirnaty®)
Not yet recruiting
- SARS-CoV-2 Infection
- PTX-COVID19-B
- Comirnaty®
- (no location specified)
Sep 7, 2022
Adenovirus Type-5 Vectored COVID-19 Vaccine Trial in Wuhan (Adenovirus Type-5 Vectored COVID-19 Vaccine)
Completed
- Adenovirus Type-5 Vectored COVID-19 Vaccine
- Adenovirus Type-5 Vectored COVID-19 Vaccine
-
Wuhan, Hubei, ChinaA rehabilitation centre in Wuhan
Mar 28, 2022
Covid-19 Vaccination Trial (Direct boost mRNA, Direct boost adeno, Post-poned boost mRNA)
Not yet recruiting
- Covid-19 Vaccination
- Direct boost mRNA
- +3 more
- (no location specified)
Jul 21, 2022
COVID-19 Trial in Tongren (Experimental vaccine 1, Experimental vaccine 2, Experimental vaccine 3)
Suspended
- COVID-19
- Experimental vaccine 1
- +2 more
-
Tongren, Guizhou, ChinaYanhe Tujia Autonomous County Center for Disease Control and Pre
Aug 9, 2022
SARS-CoV-2 Infection Trial in Groningen, Utrecht, Auckland (VLA2001)
Active, not recruiting
- SARS-CoV-2 Infection
- VLA2001
-
Groningen, Netherlands
- +3 more
Jan 17, 2023
COVID-19 Trial (LYB001, Placebo)
Not yet recruiting
- COVID-19
- LYB001
- Placebo
- (no location specified)
Oct 26, 2022